These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 26806150

  • 1. In vitro antimicrobial activity of benzoyl peroxide against Propionibacterium acnes assessed by a novel susceptibility testing method.
    Okamoto K, Ikeda F, Kanayama S, Nakajima A, Matsumoto T, Ishii R, Umehara M, Gotoh N, Hayashi N, Iyoda T, Matsuzaki K, Matsumoto S, Kawashima M.
    J Infect Chemother; 2016 Jun; 22(6):426-9. PubMed ID: 26806150
    [Abstract] [Full Text] [Related]

  • 2. Bactericidal activity and post-antibiotic effect of ozenoxacin against Propionibacterium acnes.
    Kanayama S, Okamoto K, Ikeda F, Ishii R, Matsumoto T, Hayashi N, Gotoh N.
    J Infect Chemother; 2017 Jun; 23(6):374-380. PubMed ID: 28389164
    [Abstract] [Full Text] [Related]

  • 3. In vitro antibacterial activity of NB-003 against Propionibacterium acnes.
    Pannu J, McCarthy A, Martin A, Hamouda T, Ciotti S, Ma L, Sutcliffe J, Baker JR.
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4211-7. PubMed ID: 21746943
    [Abstract] [Full Text] [Related]

  • 4. In vitro antimicrobial susceptibility patterns of Propionibacterium acnes isolated from patients with acne vulgaris.
    Biswal I, Gaind R, Kumar N, Mohanty S, Manchanda V, Khunger N, V R, Deb M.
    J Infect Dev Ctries; 2016 Oct 31; 10(10):1140-1145. PubMed ID: 27801379
    [Abstract] [Full Text] [Related]

  • 5. In-vitro investigation of anti-acne properties of Mangifera indica L. kernel extract and its mechanism of action against Propionibacterium acnes.
    Poomanee W, Chaiyana W, Mueller M, Viernstein H, Khunkitti W, Leelapornpisid P.
    Anaerobe; 2018 Aug 31; 52():64-74. PubMed ID: 29906773
    [Abstract] [Full Text] [Related]

  • 6. Advancement in benzoyl peroxide-based acne treatment: methods to increase both efficacy and tolerability.
    Fakhouri T, Yentzer BA, Feldman SR.
    J Drugs Dermatol; 2009 Jul 31; 8(7):657-61. PubMed ID: 19588642
    [Abstract] [Full Text] [Related]

  • 7. Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris.
    Sagransky M, Yentzer BA, Feldman SR.
    Expert Opin Pharmacother; 2009 Oct 31; 10(15):2555-62. PubMed ID: 19761357
    [Abstract] [Full Text] [Related]

  • 8. The impact and importance of resistance.
    Tanghetti E.
    Cutis; 2007 Jul 31; 80(1 Suppl):5-9. PubMed ID: 17824580
    [Abstract] [Full Text] [Related]

  • 9. Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris.
    Kurokawa I, Nishijima S, Kawabata S.
    Eur J Dermatol; 1999 Jul 31; 9(1):25-8. PubMed ID: 9920982
    [Abstract] [Full Text] [Related]

  • 10. Effect of topical benzoyl peroxide/clindamycin versus topical clindamycin and vehicle in the reduction of Propionibacterium acnes.
    Leyden JJ.
    Cutis; 2002 Jun 31; 69(6):475-80. PubMed ID: 12078851
    [Abstract] [Full Text] [Related]

  • 11. Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris.
    Nakatsuji T, Kao MC, Fang JY, Zouboulis CC, Zhang L, Gallo RL, Huang CM.
    J Invest Dermatol; 2009 Oct 31; 129(10):2480-8. PubMed ID: 19387482
    [Abstract] [Full Text] [Related]

  • 12. Comparative efficacy of clindamycin and benzoyl peroxide for in vivo suppression of Propionibacterium acnes.
    Gans EH, Kligman AM.
    J Dermatolog Treat; 2002 Sep 31; 13(3):107-10. PubMed ID: 12227872
    [Abstract] [Full Text] [Related]

  • 13. MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris.
    Giannopoulos L, Papaparaskevas J, Refene E, Daikos G, Stavrianeas N, Tsakris A.
    Anaerobe; 2015 Feb 31; 31():50-4. PubMed ID: 25451716
    [Abstract] [Full Text] [Related]

  • 14. Benzoyl peroxide cleansers for the treatment of acne vulgaris: status report on available data.
    Del Rosso JQ.
    Cutis; 2008 Nov 31; 82(5):336-42. PubMed ID: 19090337
    [Abstract] [Full Text] [Related]

  • 15. Antibiotic-resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%.
    Leyden JJ, Wortzman M, Baldwin EK.
    Cutis; 2008 Dec 31; 82(6):417-21. PubMed ID: 19181031
    [Abstract] [Full Text] [Related]

  • 16. Minimum Contact Time of 1.25%, 2.5%, 5%, and 10% Benzoyl Peroxide for a Bactericidal Effect Against Cutibacterium acnes.
    Boonchaya P, Rojhirunsakool S, Kamanamool N, Khunkhet S, Yooyongsatit S, Udompataikul M, Taweechotipatr M.
    Clin Cosmet Investig Dermatol; 2022 Dec 31; 15():403-409. PubMed ID: 35300432
    [Abstract] [Full Text] [Related]

  • 17. In vitro antibiotic susceptibility patterns of Propionibacterium acnes isolated from acne patients: an Egyptian university hospital-based study.
    Abdel Fattah NS, Darwish YW.
    J Eur Acad Dermatol Venereol; 2013 Dec 31; 27(12):1546-51. PubMed ID: 23279041
    [Abstract] [Full Text] [Related]

  • 18. Antibiotic resistance in the topical treatment of acne vulgaris.
    Leyden JJ.
    Cutis; 2004 Jun 31; 73(6 Suppl):6-10. PubMed ID: 15228128
    [Abstract] [Full Text] [Related]

  • 19. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.
    Nishijima S, Kurokawa I, Katoh N, Watanabe K.
    J Dermatol; 2000 May 31; 27(5):318-23. PubMed ID: 10875198
    [Abstract] [Full Text] [Related]

  • 20. Propionibacterium acnes Has Low Susceptibility to Chlorhexidine Digluconate.
    Nakase K, Fukushima H, Yukawa T, Nakaminami H, Fujii T, Noguchi N.
    Surg Infect (Larchmt); 2018 Apr 31; 19(3):298-302. PubMed ID: 29447075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.